Resources Contact Us Home
Internalizing anti-CD74 antibodies and methods of use

Image Number 15 for United States Patent #7931903.

The present invention provides humanized, chimeric and human anti-CD74 antibodies, CD74 antibody fusion proteins, immunoconjugates, vaccines and bispecific that bind to CD74, the major histocompatibility complex (MHC) class-II invariant chain, Ii, which is useful for the treatment and diagnosis of B-cell disorders, such as B-cell malignancies, other malignancies in which the cells are reactive with CD74, and autoimmune diseases, and methods of treatment and diagnosis.

  Recently Added Patents
.beta.-2 microglobulin as a biomarker for peripheral artery disease
System and method for providing an extended platform for an operating system
Process to extract quassinoids
Flexure with insulating layer isolating a portion of a metal substrate
Dynamic learning method and adaptive normal behavior profile (NBP) architecture for providing fast protection of enterprise applications
Fabrication of thin pellicle beam splitters
Permanent magnet axial field zeeman slower
  Randomly Featured Patents
Apparatus and method for signal recognition within WDM optical nodes
Centrifugal-type slide ring seal
Refrigerator cabinet refrigerant tube assembly
High bandwidth information channel with optocoupling isolation
5-Methyl-isoxazole-4-carboxylic acid anilides
Heat exchanger having an extruded, tiered heat sink
Multi-stage automatic gearbox
Fused pyrazine derivatives
Electromagnetically transparent decorative metallic surface